uniQure NV
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
公司地址 Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
電話號碼 +31 202406000
傳真號碼 --
公司網頁 https://www.uniqure.com
員工數量 221
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Matthew C. Kapusta Chief Executive Officer and Director 美元 676.17K 27/04/2026
Mr. Christian Klemt Principal Accounting Officer and Chief Financial Officer 美元 539.22K 27/04/2026
Dr. Walid Abi-Saab, M.D. Chief Medical Officer 美元 583.80K 27/04/2026
Dr. Jeannette Potts, J.D.,PhD Chief Legal and Compliance Officer 美元 495.01K 27/04/2026
Ms. Kylie OKeefe Chief Customer and Strategy Officer -- 27/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Jack L. Kaye Independent Director 27/04/2026
Dr. Leonard E. Post, PhD Independent Director 27/04/2026
Mr. Matthew C. Kapusta Chief Executive Officer and Director 27/04/2026
Mr. David D. Meek Chairman of the Board 27/04/2026
Mr. Madhavan Balachandran Independent Director 27/04/2026
Dr. Jeremy P. Springhorn, PhD Independent Director 27/04/2026
Dr. Robert Gut, M.D.,PhD Independent Director 27/04/2026
Ms. Rachelle S. Jacques Independent Director 27/04/2026
 
所屬ETF (更新日期: 19/09/2026 03:21)
代號 名稱 佔比% ▼ 持有日期
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
AVTMAvantis Total Equity Markets ETF<0.000001%24/07/2026
BMEBlackRock Health Sciences<0.000001%31/03/2026
BMEZBlackRock Health Sciences Term Trust<0.000001%31/03/2026
CGOCalamos Global Total Return<0.000001%30/11/2025
CHWCalamos Global Dynamic Income<0.000001%30/11/2025
EHLSEven Herd Long Short ETF<0.000001%28/04/2026
ESIMEventide International ETF<0.000001%11/06/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
FFSMFidelity Fundamental Small-Mid Cap ETF<0.000001%30/06/2026
FRTYAlger Mid Cap 40 ETF<0.000001%18/11/2025
HELXFranklin Genomic Advancements ETF<0.000001%09/12/2025
HRTSTema Heart & Health ETF<0.000001%08/12/2025
IDNAiShares Genomics Immnlgy & Hlthcr ETF<0.000001%06/03/2026
ISCGiShares Morningstar Small-Cap Growth ETF<0.000001%18/06/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF<0.000001%01/06/2023
PRFZInvesco RAFI US 1500 Small-Mid ETF<0.000001%23/12/2025
QQQSInvesco NASDAQ Future Gen 200 ETF<0.000001%23/12/2025
RKNGDefiance Retail Kings ETF<0.000001%23/03/2026
RUSCRussell Inv U.S. Small Cap Equity ETF<0.000001%05/12/2025
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.